PHT Corporation Articulates Scientific and Business Benefits of ePRO at Prestigious Pharmaceutical Industry Events
Executives of ePRO market leader continue their expert education of pharmaceutical sponsors with scientific talks at industry conferences this month
BOSTON, Mass. – October 16, 2009 – PHT Corporation, the leading provider of ePRO solutions used in pharmaceutical and biotechnology clinical trials worldwide, continues to herald industry advances and best practices with its dominance in thought conferences.
This month PHT scientific and business executives will speak at industry events worldwide to impart information about merging data capture technology systems for efficient clinical trials; leveraging eClinical guidance for improved data quality; and validating questionnaires when transitioning platforms.
• DIA 3rd Annual Clinical Forum, October 19-21 in Nice, France – Vice President of Product Management and Marketing Sheila Rocchio will present a talk about the Role of SMS Applications in Clinical Research. General Manager of PHT Europe Valdo Arnera, MD will lead a session about eClinical standards. PHT also will demonstrate its industry-leading ePRO solutions at Booth # 22.
• ISPOR 12th Annual European Congress, October 24-27 in Paris, France – PHT will demonstrate how ePRO simplifies Health Outcomes data collection at Booth # 86.
• DIA Study Endpoints Meeting, 26-27 October 12, 2009 in New Orleans, Louisiana – Dr. Arnera will discuss a physician’s view of the Importance of Methods Used for Report-based Measures in Multinational Clinical Trials. Dr. Arnera recently published ‘Why Paper Should Be Banned in Clinical Trials’, available at http://www.phtcorp.com/pdf/arnera.pdf.
• ISOQOL 16th Annual Conference, October 28-31 in New Orleans, Louisiana – PHT Director of Clinical Operations and Scientific Advisor Dr. Barbara Marino will present a talk on maintaining the integrity of PRO instruments. Dr. Marino is regarded as the industry expert in eDiary design.
About PHT Corporation
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 400 clinical trials by 100 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad® Tablet deliver the voice of the patient, in 88 languages, from homes and sites in 65 countries around the world. By capturing high-quality and time-stamped assessments with minimal respondent burden, trial sponsors are able to run smaller and more conclusive clinical research programs resulting in significant R&D cost savings. Real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry’s premier study archive. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least 12 NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com.
PHT, LogPad, eSense, StudyWorks, SafetyPRO and SitePad are among the registered trademarks and trademarks of PHT Corporation.
Contact: Brenda Nashawaty, bnashawaty@phtcorp.com, 617-688-3253
###
